Overview Dividends

(MOH) Molina Healthcare - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US60855R1005

Medicaid, Medicare, Marketplace

MOH EPS (Earnings per Share)

EPS Growth (3Y CAGR): -25.27%
EPS Trend (3Y Correlation): -29.8%

MOH Revenue

Revenue Growth (3Y CAGR): 40.61%
Revenue Trend (3Y Correlation): 82.4%

Risk via 10d forecast
Volatility	57.9%
Value at Risk 5%th	87.7%

Reward
Sharpe Ratio	-1.39
Alpha	-68.26

Character
Hurst Exponent	0.364
Beta	0.553

Drawdowns 3y
Max DD	66.41%
Mean DD	21.68%

Description: MOH Molina Healthcare November 03, 2025

Molina Healthcare (MOH) is a U.S.-based managed-care insurer that primarily serves low-income populations through Medicaid, Medicare, and state health-insurance marketplaces, operating in 21 states from its headquarters in Long Beach, California.

Key metrics as of the latest filing show total enrollment of roughly 4.5 million members, with Medicaid accounting for about 70 % of the mix; the company posted FY 2023 revenue of $7.6 billion and an adjusted operating margin near 3 %, reflecting modest profitability in a cost-pressured environment. Growth is driven by ongoing Medicaid expansion in several states, rising demand for Medicare Advantage plans, and the broader trend of health-care cost inflation that supports higher reimbursement rates.

For a deeper quantitative dive into MOH’s valuation dynamics, consider exploring the analytics available on ValueRay.

MOH Stock Overview

Market Cap in USD	7,557m
Sub-Industry	Managed Health Care
IPO / Inception	2003-07-02
Return 12m vs S&P 500	-62.2%
Analyst Rating	3.75 of 5

MOH Dividends

Currently no dividends paid

MOH Growth Ratios

CAGR	-22.99%
CAGR/Max DD Calmar Ratio	-0.35
CAGR/Mean DD Pain Ratio	-1.06
Current Volume	1615.7k
Average Volume	1615.7k

Piotroski VR‑10 (Strict, 0-10) 5.5

Net Income (883.0m TTM) > 0 and > 6% of Revenue (6% = 3.24b TTM)

FCFTA -0.04 (>2.0%) and ΔFCFTA -4.25pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 9.38% (prev 11.59%; Δ -2.21pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA -0.03 (>3.0%) and CFO -461.0m <= Net Income 883.0m (YES >=105%, WARN >=100%)

Net Debt (-369.0m) to EBITDA (1.52b) ratio: -0.24 <= 3.0 (WARN <= 3.5)

Current Ratio 1.68 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (53.6m) change vs 12m ago -7.11% (target <= -2.0% for YES)

Gross Margin 8.19% (prev 11.90%; Δ -3.71pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 343.8% (prev 248.8%; Δ 95.00pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 7.60 (EBITDA TTM 1.52b / Interest Expense TTM 174.0m) >= 6 (WARN >= 3)

Altman Z'' 3.81

(A) 0.32 = (Total Current Assets 12.55b - Total Current Liabilities 7.48b) / Total Assets 15.70b

(B) 0.24 = Retained Earnings (Balance) 3.76b / Total Assets 15.70b

(D) 0.33 = Book Value of Equity 3.77b / Total Liabilities 11.51b

Total Rating: 3.81 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 69.05

1. Piotroski 5.50pt = 0.50

2. FCF Yield -7.99% = -3.99

3. FCF Margin -1.06% = -0.40

4. Debt/Equity 0.92 = 2.09

5. Debt/Ebitda -0.24 = 2.50

6. ROIC - WACC (= 9.59)% = 11.98

7. RoE 20.07% = 1.67

8. Rev. Trend 82.41% = 6.18

9. EPS Trend -29.83% = -1.49

What is the price of MOH shares?

As of November 12, 2025, the stock is trading at USD 143.52 with a total of 1,615,700 shares traded.
Over the past week, the price has changed by -5.39%, over one month by -26.12%, over three months by -6.70% and over the past year by -56.32%.

Is Molina Healthcare a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Molina Healthcare (NYSE:MOH) is currently (November 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 69.05 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of MOH is around 116.40 USD . This means that MOH is currently overvalued and has a potential downside of -18.9%.

Is MOH a buy, sell or hold?

Molina Healthcare has received a consensus analysts rating of 3.75. Therefor, it is recommend to hold MOH.

Strong Buy: 6
Buy: 1
Hold: 8
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the MOH price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	176.9	23.3%
Analysts Target Price	176.9	23.3%
ValueRay Target Price	126.6	-11.8%

MOH Fundamental Data Overview November 05, 2025

Market Cap USD = 7.56b (7.56b USD * 1.0 USD.USD)
P/E Trailing = 9.048
P/E Forward = 9.6805
P/S = 0.1764
P/B = 2.2873
P/EG = -0.62
Beta = 0.553
Revenue TTM = 54.07b USD
EBIT TTM = 1.32b USD
EBITDA TTM = 1.52b USD
Long Term Debt = 2.92b USD (from longTermDebt, last fiscal year)
Short Term Debt = 15.0m USD (from shortTermDebt, last fiscal year)
Debt = 3.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -369.0m USD (from netDebt column, last quarter)
Enterprise Value = 7.19b USD (7.56b + Debt 3.85b - CCE 4.22b)
Interest Coverage Ratio = 7.60 (Ebit TTM 1.32b / Interest Expense TTM 174.0m)
FCF Yield = -7.99% (FCF TTM -574.0m / Enterprise Value 7.19b)
FCF Margin = -1.06% (FCF TTM -574.0m / Revenue TTM 54.07b)
Net Margin = 1.63% (Net Income TTM 883.0m / Revenue TTM 54.07b)
Gross Margin = 8.19% ((Revenue TTM 54.07b - Cost of Revenue TTM 49.64b) / Revenue TTM)
Gross Margin QoQ = 4.13% (prev 10.21%)
Tobins Q-Ratio = 0.46 (Enterprise Value 7.19b / Total Assets 15.70b)
Interest Expense / Debt = 1.27% (Interest Expense 49.0m / Debt 3.85b)
Taxrate = 10.23% (9.00m / 88.0m)
NOPAT = 1.19b (EBIT 1.32b * (1 - 10.23%))
Current Ratio = 1.68 (Total Current Assets 12.55b / Total Current Liabilities 7.48b)
Debt / Equity = 0.92 (Debt 3.85b / totalStockholderEquity, last quarter 4.19b)
Debt / EBITDA = -0.24 (Net Debt -369.0m / EBITDA 1.52b)
Debt / FCF = 0.64 (negative FCF - burning cash) (Net Debt -369.0m / FCF TTM -574.0m)
Total Stockholder Equity = 4.40b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.62% (Net Income 883.0m / Total Assets 15.70b)
RoE = 20.07% (Net Income TTM 883.0m / Total Stockholder Equity 4.40b)
RoCE = 18.07% (EBIT 1.32b / Capital Employed (Equity 4.40b + L.T.Debt 2.92b))
RoIC = 15.30% (NOPAT 1.19b / Invested Capital 7.76b)
WACC = 5.72% (E(7.56b)/V(11.41b) * Re(8.05%) + D(3.85b)/V(11.41b) * Rd(1.27%) * (1-Tc(0.10)))
Discount Rate = 8.05% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.03%
Fair Price DCF = unknown (Cash Flow -574.0m)
EPS Correlation: -29.83 | EPS CAGR: -25.27% | SUE: -4.0 | # QB: 0
Revenue Correlation: 82.41 | Revenue CAGR: 40.61% | SUE: 4.0 | # QB: 5

Additional Sources for MOH Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle